Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on H acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104480181A reveals enzymatic D-7-ACA synthesis offering high purity and yield. This process enables cost reduction in pharmaceutical intermediates manufacturing and supply chain stability.
Patent CN103555807B reveals one-step enzymatic route for 7-ACA. Offers high purity, reduced waste, and cost-effective supply chain solutions for global buyers.
Novel borohydride reduction process yields 95% pure intermediates. Cost-effective scalable synthesis for global pharmaceutical and agrochemical supply chains.
Patent CN110467527A reveals ruthenium-catalyzed route for high-purity agrochemical intermediate with significant cost and supply chain advantages.
Patent CN101619077B reveals a lime-based hydrolysis route for PMIDA, offering significant cost reduction and environmental benefits for agrochemical intermediate manufacturing supply chains.
This patent details a novel synthesis for spiro borate esters used in optoelectronics. It offers high purity and thermal stability for reliable supply chains.
Novel iodination method ensures high purity and significant cost reduction in pharmaceutical intermediate manufacturing for global supply chains. This patent offers scalable routes for API precursors.
Patent CN108948105A details a novel five-step chemical synthesis for high-purity GAMG. This process offers significant supply chain stability and cost reduction advantages.
Patent CN110869383A reveals enzymatic synthesis of beta-hydroxy-alpha-amino acids with high stereoselectivity and reduced environmental impact for supply chains.
Patent CN108610253B details a green one-step Suzuki coupling for Flubensalicylic acid. Achieve 98.37% yield with ligand-free palladium catalysis for cost-effective manufacturing.
Patent CN105177065A enables high-purity alpha-ketoglutaric acid production via yeast biotransformation, offering significant supply chain and cost advantages.
Novel chiral resolution route for high-purity tetrahydroisoquinoline intermediates. Cost-effective, scalable process for peptide drug synthesis.
Patent CN118879653A reveals high-efficiency DAAO mutant for L-glufosinate production. Achieves 99% conversion with reduced costs and enhanced supply chain reliability for global agrochemical manufacturers.
Novel synthesis method for tetrahydropyran-3-boronic acid pinacol ester offers scalable production and cost efficiency for pharmaceutical supply chains.
Novel resolution method for cis-chiral intermediate. Reduces cost and improves scalability for pharmaceutical manufacturing supply chains.
Novel metal-free C5 iodination of indoles using NIS or I2. High regioselectivity, mild conditions. Ideal for API intermediates. Cost-effective scale-up.
Novel Reppe synthesis route for strawberry acid using Rh-catalysis. High yield, green chemistry, cost-effective manufacturing for flavor industry.
Patent CN114908129B reveals a novel dehydrogenase mutant for high-purity (R)-4-chloro-3-hydroxybutyric acid ethyl ester production, offering significant cost and supply chain advantages.
Novel esterification-crystallization method removes double oxide impurities, ensuring superior quality for ursodeoxycholic acid production.
Novel epoxidation reagent replacing toxic dimethyl sulfide. Recyclable, water-soluble, high yield. Reliable supplier for pharmaceutical intermediates.